Shelton资本管理公司出售了近91 000张安根股票,但该公司在财政上仍然强劲。 Shelton Capital Management sold nearly 91,000 Amgen shares, but the company remains financially strong.

Shelton资本管理公司在第四季度出售90 975股,减少了对Amgen公司的持有量,留下83 769股,价值2 180万美元。 Shelton Capital Management reduced its holdings of Amgen Inc. by selling 90,975 shares in the fourth quarter, leaving it with 83,769 shares valued at $21.8 million. 尽管如此，安进仍拥有强大的财务状况，股息收益率为 3.29%，分析师预计今年的每股收益为 20.62 美元。 Despite this, Amgen has a strong financial standing with a dividend yield of 3.29% and analysts projecting earnings of $20.62 per share for the current year. 该公司侧重于发展各种医疗条件的治疗方法。 The company focuses on developing therapeutics for various medical conditions.